SHPMF (Shanghai Pharmaceuticals Holding Co) PB Ratio: 0.48 (As of Jul. 01, 2026) — 60% Below Median


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.86
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co PB Ratio?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 PB Ratio is 0.48 as of Jul. 01, 2026, which is 60% below its 10-year median of 1.19. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.86. The stock has 4 warning signs investors should review. Among 110 Medical Distribution companies, Shanghai Pharmaceuticals Holding Co ranks better than 73.64% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-01), Shanghai Pharmaceuticals Holding Co's share price is $1.46. Shanghai Pharmaceuticals Holding Co's Book Value per Share for the quarter that ended in Mar. 2026 was $3.02. Hence, Shanghai Pharmaceuticals Holding Co's PB Ratio of today is 0.48.

Good Sign:

Shanghai Pharmaceuticals Holding Co Ltd stock PB Ratio (=0.75) is close to 10-year low of 0.73.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's PB Ratio or its related term are showing as below:

SHPMF' s PB Ratio Range Over the Past 10 Years
Min: 0.73   Med: 1.19   Max: 2.39
Current: 0.75

During the past 13 years, Shanghai Pharmaceuticals Holding Co's highest PB Ratio was 2.39. The lowest was 0.73. And the median was 1.19.

SHPMF's PB Ratio is ranked better than
73.64% of 110 companies
in the Medical Distribution industry
Industry Median: 1.015 vs SHPMF: 0.75

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average Book Value Per Share Growth Rate was 5.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 4.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 6.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Pharmaceuticals Holding Co was 74.00% per year. The lowest was -14.30% per year. And the median was 7.20% per year.

Back to Basics: PB Ratio


Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Shanghai Pharmaceuticals Holding Co PB Ratio Related Terms


Shanghai Pharmaceuticals Holding Co PB Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co PB Ratio Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.62 0.60 0.62 0.50

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.55 0.53 0.50 0.48

SHPMF vs MCK, CAH, COR: PB Ratio Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's PB Ratio falls into.


SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Shanghai Pharmaceuticals Holding Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=1.46/3.024
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.48 mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a PB Ratio of 0.48 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. This is 60% below median its historical median of 1.19. Over the past decade, Shanghai Pharmaceuticals Holding Co's PB Ratio has ranged from 0.73 to 2.39. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #29 out of 110 companies in the Medical Distribution industry, placing it in the top 26.4%.
Is Shanghai Pharmaceuticals Holding Co's PB Ratio too high?
Shanghai Pharmaceuticals Holding Co's current PB Ratio of 0.48 is 60% below median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.39. The Medical Distribution industry median PB Ratio is 1.02. Shanghai Pharmaceuticals Holding Co's value of 0.48 is 52.7% below this industry median. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #29 out of 110 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #29 out of 110 companies for PB Ratio. This puts Shanghai Pharmaceuticals Holding Co in the upper half of its industry. The industry median PB Ratio is 1.02. Shanghai Pharmaceuticals Holding Co's value of 0.48 is 52.7% below this benchmark. Historically, Shanghai Pharmaceuticals Holding Co's own PB Ratio has ranged from 0.73 to 2.39 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 1.02, Shanghai Pharmaceuticals Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.02, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current PB Ratio of 0.48 is 52.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current PB Ratio is 0.48, which is 60% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current PB Ratio of 0.48. The stock's GF Value™ is $1.86, compared to a current price of $1.46 — trading 21.5% below its estimated fair value. The current PB Ratio is 0.48, which is 60% below median its 10-year median of 1.19 and 52.7% below the Medical Distribution industry median of 1.02. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current PB Ratio is 0.48 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 21.5% below its estimated GF Value™ of $1.86.

Key valuation signals for SHPMF:

  • PB Ratio: 0.48 (60% below median its 10-year median of 1.19)
  • GF Value™: $1.86 vs. price of $1.46 (21.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 52.7% below the Medical Distribution median (#29 of 110)

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.86
GF Value